Insider Selling: CRISPR Therapeutics (NASDAQ:CRSP) CEO Sells 4,098 Shares of Stock

Insider Selling: CRISPR Therapeutics (NASDAQ:CRSP) CEO Sells 4,098 Shares of Stock

CRISPR Therapeutics AG (NASDAQ:CRSP - Get Free Report) CEO Samarth Kulkarni sold 4,098 shares of CRISPR Therapeutics stock in a transaction that occurred on Wednesday, October 14th. The shares were sold at an average price of $49.26, for a total transaction of $201,867.48. Following the completion of the sale, the chief executive officer owned 259,736 shares of the company's stock, valued at $12,794,595.36. This trade represents a 1.55% decrease…

CRISPR Therapeutics (NASDAQ:CRSP) General Counsel James Kasinger Sells 1,040 Shares of Company Stock

CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) General Counsel James Kasinger sold 1,040 shares of the business’s stock in a transaction on Wednesday, October 14th. The shares were sold at an average price of $49.26, for a total transaction of $51,230.40. Following the completion of the sale, the general counsel owned 95,857 shares in […]